TyraTech
<< < > >>
Search:
 
| Full PDF report | Print this page |
Annual Report & Accounts 2010 - Notes
slide
<< < > >>
Notes to Consolidated Financial Statements (CON TINUE D) (12) Research and Development Collaborati ons The Company has the following significant research and development collaborative agreement outstanding at December 31, 2010 and 2009: Kraft Agreement Summary On December 5, 2006, the Company entered into a technology sublicense agreement with Kraft. Pursuant to this agreement, Kraft was granted a limited exclusive sublicense to use the Company's know-how and related license and patents relating to the production of "functional foods" which treat and prevent parasites in humans through additives to foods, beverages and dietary supplements. Kraft is required to use commercially reasonable efforts to pursue the achievement of milestones set out in the agreement. The project for the development of licensed products is divided into four development stages. Within each stage certain designated milestones are to be accomplished in accordance with the development and implementation priorities agreed by the parties. The Company has the obligation to fund product development with a portion of the product development funded through an upfront payment and milestone payments from Kraft. The agreement was revised in September 2009, to better address the ongoing development plan. With completion of the second milestone, and under the revised agreement, TyraTech will receive a bi-annual cost reimbursement for agreed upon development costs for what would have been stages three and four. TyraTech will continue to receive an exclusivity fee from Kraft Foods for each stage three and four. The Company and Kraft agreed to negotiate a supply agreement in "good faith" after commercial launch. In addition, Kraft has agreed to pay the Company royalties for any product sales related to the "functional foods" with the Company's technology. Accounting Summary The Company considers its arrangement with Kraft to be a revenue arrangement with multiple deliverables. The Company's deliverables under this collaboration include an exclusive license to its parasitic technologies, research and development services and participation on a steering committee. The Company determined that the deliverables, specifically the license, research and development services and steering committee participation, represented a single unit of accounting because the Company believes that the license, although delivered at the inception of the arrangement, does not have stand-alone value to Kraft without the Company's research and development services and steering committee participation and because objective and reliable evidence of the fair value of the Company's research and development services and steering committee participation could not be determined. (13) 401(k) Plan The Company maintains a defined contribution 401(k) plan. The 401(k) plan is designed in accordance with the applicable sections of the Internal Revenue Code, and is subject to minimum 3% funding requirements as required as a safe harbor plan. The 401(k) plan covers all eligible employees of the Company and its subsidiaries upon completion of three months of service. Employees may elect to contribute up to a maximum of 60% of their salary, subject to Internal Revenue Service limitations. The Company has a matching policy in which the Company matches 100% of the first 4% of each employee's compensation contributed to the 401(k) plan. For the years ended December 31, 2010 and 2009, the Company's contribution, including administrative expenses, amounted to US $62,936 and US $99,611 and are charged to general and administrative, business and development, and research and technical development expenses in Consolidated Statements of Operations. (14) Income Taxes Beginning on May 24, 2007 the Company is subject to both federal and state income taxes. For the period prior to May 24, 2007, the Company operated as a pass through entity for tax purposes and tax liability was the responsibility of its members. The difference between the "expected" tax benefit (computed by applying the federal corporate income tax rate of 34% to the loss before income taxes) and the actual tax benefit is primarily due to the effect of the valuation allowance described below. Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and amounts utilized 42